Release test results
99.685%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 30.24 mg
Related impurities (total)0.315%
Endotoxin<1.0 EU/mg
HPLC retention time5.41 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundGLP-1-SM
Presentation30 MG
Lot numberRGX-26-GLP-1010
COA numberNS-2026-05011
Test date03 Aug 2026
Release date06 Aug 2026
Independent labNordicstar Labs
StatusCurrent
GLP-1-SM — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-GLP-1007 | 10 MG | Aug 4, 2026 | 99.763% | Current |
| RGX-26-GLP-1008 | 15 MG | Aug 4, 2026 | 99.580% | Current |
| RGX-26-GLP-1009 | 20 MG | Aug 3, 2026 | 99.723% | Current |
| RGX-26-GLP-1010 this lot | 30 MG | Aug 3, 2026 | 99.685% | Current |
| RGX-26-GLP-790 | 30 MG | Apr 26, 2026 | 99.705% | Superseded |
| RGX-26-GLP-793 | 10 MG | Apr 24, 2026 | 99.697% | Superseded |
| RGX-26-GLP-792 | 15 MG | Apr 23, 2026 | 99.636% | Superseded |
| RGX-26-GLP-791 | 20 MG | Apr 20, 2026 | 99.712% | Superseded |
| RGX-26-GLP-691 | 20 MG | Jan 25, 2026 | 99.743% | Superseded |
| RGX-26-GLP-690 | 30 MG | Jan 23, 2026 | 99.598% | Superseded |
| RGX-26-GLP-693 | 10 MG | Jan 22, 2026 | 99.674% | Superseded |
| RGX-26-GLP-692 | 15 MG | Jan 20, 2026 | 99.750% | Superseded |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →